Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 21

1.

Vertebral fracture risk after once-weekly teriparatide injections: follow-up study of Teriparatide Once-Weekly Efficacy Research (TOWER) trial.

Sugimoto T, Shiraki M, Nakano T, Kishimoto H, Ito M, Fukunaga M, Hagino H, Sone T, Kuroda T, Nakamura T.

Curr Med Res Opin. 2013 Mar;29(3):195-203. doi: 10.1185/03007995.2012.761956. Epub 2013 Jan 17.

PMID:
23259702
[PubMed - indexed for MEDLINE]
2.

Effect of teriparatide on bone mineral density and fracture in postmenopausal osteoporosis: meta-analysis of randomised controlled trials.

Han SL, Wan SL.

Int J Clin Pract. 2012 Feb;66(2):199-209. doi: 10.1111/j.1742-1241.2011.02837.x. Review.

PMID:
22257045
[PubMed - indexed for MEDLINE]
3.

Beyond daily dosing: clinical experience.

Cooper C.

Bone. 2006 Apr;38(4 Suppl 1):S13-7. Epub 2006 Mar 7. Review.

PMID:
16520105
[PubMed - indexed for MEDLINE]
4.

A systematic review and economic evaluation of alendronate, etidronate, risedronate, raloxifene and teriparatide for the prevention and treatment of postmenopausal osteoporosis.

Stevenson M, Jones ML, De Nigris E, Brewer N, Davis S, Oakley J.

Health Technol Assess. 2005 Jun;9(22):1-160. Review.

PMID:
15929857
[PubMed - indexed for MEDLINE]
Free Article
5.

Bisphosphonates for osteoporosis in people with cystic fibrosis.

Conwell LS, Chang AB.

Cochrane Database Syst Rev. 2012 Apr 18;4:CD002010. doi: 10.1002/14651858.CD002010.pub3. Review. Update in: Cochrane Database Syst Rev. 2014;3:CD002010.

PMID:
22513903
[PubMed - indexed for MEDLINE]
6.

Teriparatide (biosynthetic human parathyroid hormone 1-34): a new paradigm in the treatment of osteoporosis.

Brixen KT, Christensen PM, Ejersted C, Langdahl BL.

Basic Clin Pharmacol Toxicol. 2004 Jun;94(6):260-70. Review.

PMID:
15228497
[PubMed - indexed for MEDLINE]
7.

Strontium ranelate for preventing and treating postmenopausal osteoporosis.

O'Donnell S, Cranney A, Wells GA, Adachi JD, Reginster JY.

Cochrane Database Syst Rev. 2006 Jul 19;(3):CD005326. Review. Update in: Cochrane Database Syst Rev. 2006;(4):CD005326.

PMID:
16856092
[PubMed - indexed for MEDLINE]
8.

Update on monthly oral bisphosphonate therapy for the treatment of osteoporosis: focus on ibandronate 150 mg and risedronate 150 mg.

Epstein S, Jeglitsch M, McCloskey E.

Curr Med Res Opin. 2009 Dec;25(12):2951-60. doi: 10.1185/03007990903361307. Review.

PMID:
19835464
[PubMed - indexed for MEDLINE]
9.

Reduced risk of back pain following teriparatide treatment: a meta-analysis.

Nevitt MC, Chen P, Dore RK, Reginster JY, Kiel DP, Zanchetta JR, Glass EV, Krege JH.

Osteoporos Int. 2006 Feb;17(2):273-80. Epub 2005 Sep 2. Review.

PMID:
16142502
[PubMed - indexed for MEDLINE]
10.

Review of treatment modalities for postmenopausal osteoporosis.

Hamdy RC, Chesnut CH 3rd, Gass ML, Holick MF, Leib ES, Lewiecki ME, Maricic M, Watts NB.

South Med J. 2005 Oct;98(10):1000-14; quiz 1015-7, 1048. Review.

PMID:
16295815
[PubMed - indexed for MEDLINE]
11.

Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use.

Hodsman AB, Bauer DC, Dempster DW, Dian L, Hanley DA, Harris ST, Kendler DL, McClung MR, Miller PD, Olszynski WP, Orwoll E, Yuen CK.

Endocr Rev. 2005 Aug;26(5):688-703. Epub 2005 Mar 15. Review.

PMID:
15769903
[PubMed - indexed for MEDLINE]
12.

[Zoledronic acid reduces risk of any new clinical fracture and risk of death after surgical repair of a low-trauma hip fracture].

Leszczyński P.

Chir Narzadow Ruchu Ortop Pol. 2010 May-Jun;75(3):168-71. Review. Polish.

PMID:
21038635
[PubMed - indexed for MEDLINE]
13.

Management of glucocorticoid-induced osteoporosis.

Rizzoli R, Adachi JD, Cooper C, Dere W, Devogelaer JP, Diez-Perez A, Kanis JA, Laslop A, Mitlak B, Papapoulos S, Ralston S, Reiter S, Werhya G, Reginster JY.

Calcif Tissue Int. 2012 Oct;91(4):225-43. doi: 10.1007/s00223-012-9630-5. Epub 2012 Aug 10. Review.

PMID:
22878667
[PubMed - indexed for MEDLINE]
14.

Clinical review. Comparative effectiveness of drug treatments to prevent fragility fractures: a systematic review and network meta-analysis.

Murad MH, Drake MT, Mullan RJ, Mauck KF, Stuart LM, Lane MA, Abu Elnour NO, Erwin PJ, Hazem A, Puhan MA, Li T, Montori VM.

J Clin Endocrinol Metab. 2012 Jun;97(6):1871-80. doi: 10.1210/jc.2011-3060. Review.

PMID:
22466336
[PubMed - indexed for MEDLINE]
15.

Glucocorticoid-induced osteoporosis.

Silverman SL, Lane NE.

Curr Osteoporos Rep. 2009 Mar;7(1):23-6. Review.

PMID:
19239826
[PubMed - indexed for MEDLINE]
16.

Treatment of premenopausal women with low bone mineral density.

Cohen A, Shane E.

Curr Osteoporos Rep. 2008 Mar;6(1):39-46. Review.

PMID:
18430399
[PubMed - indexed for MEDLINE]
17.

The effects of organic nitrates on osteoporosis: a systematic review.

Jamal SA, Reid LS, Hamilton CJ.

Osteoporos Int. 2013 Mar;24(3):763-70. doi: 10.1007/s00198-012-2262-9. Epub 2013 Jan 11. Review.

PMID:
23306823
[PubMed - indexed for MEDLINE]
18.

Emerging therapeutic opportunities for skeletal restoration.

Kawai M, Mödder UI, Khosla S, Rosen CJ.

Nat Rev Drug Discov. 2011 Feb;10(2):141-56. doi: 10.1038/nrd3299. Review.

PMID:
21283108
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Bisphosphonate use in acute and chronic spinal cord injury: a systematic review.

Bryson JE, Gourlay ML.

J Spinal Cord Med. 2009;32(3):215-25. Review.

PMID:
19810623
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

[Effect of anti-osteoporotic agents on cortical microstructure].

Ito M.

Clin Calcium. 2013 Jul;23(7):1035-9. doi: CliCa130710351039. Review. Japanese.

PMID:
23811593
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk